Almotriptan
| Use attributes for filter ! | |
| Molar mass | 335. 465 g/mol |
|---|---|
| Bioavailability | 70% |
| CAS ID | 181183-52-8 |
| Trade name | Axert |
| Metabolism | Hepatic |
| Elimination half-life | 3–4 hours |
| Music groups | Naratriptan |
| Eletriptan | |
| Rizatriptan | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2951281 |
About Almotriptan
Almotriptan is a triptan drug discovered and developed by Almirall for the treatment of heavy migraine headache. It was patented in 1992 and approved for medical use in 2000.